Companies / ABT vs ZTS
ABT vs ZTS: Abbott Laboratories and Zoetis
Abbott Laboratories (ABT) reported $44.3B in revenue against a 14.7% net margin, while Zoetis (ZTS) reported $9.5B at a 28.2% net margin, most recently.
| Metric | ABT | ZTS |
|---|---|---|
| Revenue | $44.3B | $9.5B |
| Net Income | $6.5B | $2.7B |
| Gross Margin | 56.4% | 71.8% |
| Operating Margin | 18.2% | — |
| EPS (Diluted) | $3.72 | $6.02 |
| Free Cash Flow | $7.4B | $2.3B |
| Total Debt | $12.9B | $9.0B |
| P/E Ratio | 33.7× | 20.9× |
| P/B Ratio | n/m | 16.1× |
| Stock Price | $112.71 | $82.13 |
Free: last 5 years
| Fiscal year | FY2011 🔒 | FY2012 🔒 | FY2013 🔒 | FY2014 🔒 | FY2015 🔒 | FY2016 🔒 | FY2017 🔒 | FY2018 🔒 | FY2019 🔒 | FY2020 🔒 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ABT Revenue | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $43.1B | $43.7B | $40.1B | $42.0B | $44.3B |
| ZTS Revenue | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $7.8B | $8.1B | $8.5B | $9.3B | $9.5B |